Erez Daniella Levy, Derwick Hannah, Furth Susan, Ballester Lance, Omuemu Stephanie, Adiri Yonathan, Mink Jonah, Denburg Michelle
Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pediatr Nephrol. 2023 Jan;38(1):139-143. doi: 10.1007/s00467-022-05556-8. Epub 2022 Apr 21.
Monitoring proteinuria in patients with kidney disease is of crucial importance given its implications for long-term disease progression and clinical management. Leveraging digital health technology to provide a clinical grade urinalysis result from home holds the potential to greatly enhance the clinical experience and workflows for patients, caregivers, and providers. The goal of this study was to evaluate the acceptability and feasibility of a home-based urinalysis kit using a smartphone application.
This is a prospective cohort study of children and young adults (5-21 years of age) at a single pediatric center. The study received ethical board approval. Families performed a home urine test using the Healthy.io smartphone app. The app was compared with standard of care of either home dipstick monitoring or urinalysis performed in clinic or a local laboratory. Patient satisfaction was compared between the new app and current practice.
A total of 103 children, 63 (61%) male and median age 10.9 years (inter-quartile range 7.8-14.2), were enrolled. Primary diagnosis included 47 (46%) glomerular disease, 48 (47%) non-glomerular kidney disease, and 8 (8%) kidney transplant recipients. One hundred and one (98%) patients reported being satisfied with the smartphone app compared to 41 (40%) patients who were satisfied with the current practice for urine protein monitoring (p < 0.0001). Positive themes identified included ease of use, convenience, and immediacy and accuracy of results.
The Healthy.io home urine testing app received very high rates of satisfaction among patients and caregivers compared to current practice and holds great potential to enhance patient-centered care. A higher resolution version of the Graphical abstract is available as Supplementary information.
鉴于蛋白尿对肾病患者长期疾病进展和临床管理的影响,监测肾病患者的蛋白尿至关重要。利用数字健康技术在家中提供临床级别的尿液分析结果,有可能极大地改善患者、护理人员和医疗服务提供者的临床体验和工作流程。本研究的目的是评估一款使用智能手机应用程序的家庭尿液分析试剂盒的可接受性和可行性。
这是一项在单一儿科中心对儿童和年轻人(5至21岁)进行的前瞻性队列研究。该研究获得了伦理委员会的批准。家庭使用Healthy.io智能手机应用程序进行家庭尿液检测。将该应用程序与家庭试纸监测或在诊所或当地实验室进行尿液分析的标准护理方法进行比较。比较新应用程序与当前做法之间的患者满意度。
共招募了103名儿童,其中63名(61%)为男性,中位年龄为10.9岁(四分位间距7.8 - 14.2)。主要诊断包括47例(46%)肾小球疾病、48例(47%)非肾小球肾病和8例(8%)肾移植受者。与41名(40%)对当前尿液蛋白监测做法感到满意的患者相比,101名(98%)患者报告对智能手机应用程序感到满意(p < 0.0001)。确定的积极主题包括易用性、便利性以及结果的即时性和准确性。
与当前做法相比,Healthy.io家庭尿液检测应用程序在患者和护理人员中获得了非常高的满意度,并且在增强以患者为中心的护理方面具有巨大潜力。更高分辨率的图形摘要版本可作为补充信息获取。